Thomas J. Polascik, MD

Related Content

Locations

• Duke Urology of Raleigh

Services

• Prostate Cancer
• Urology

Department / Division:
Surgery / Urology

Address:
DUMC 2804
Durham, NC 27710

Appointment Telephone:
919-684-2446 or 919-684-4946

Office Telephone:
919-684-4946

Fax Telephone:
919-684-5220

• MD, University of Chicago, Pritzker School of Medicine, Illinois, 1991

• General Surgery, Johns Hopkins Hospital, Maryland, 1991-1993
• Urology, James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Maryland, 1993-1997

• Urologic Oncology, Johns Hopkins Hospital, Maryland, 1997-1998

Clinical Interests:
Robotic nerve-sparing prostate cancer surgery, urologic oncology, nerve-sparing radical prostate surgery, laparoscopic and minimally-invasive kidney surgery, prostate and kidney cryosurgery, focal therapy for prostate cancer

Research Interests:
Prostate cancer imaging
Focal therapy of prostate cancer
Prostate cancer outcomes
Minimally invasive surgery
Nerve sparing cryotherapy

Representative Publications:
Sun L, Moul JW, Hotaling JM, Rampersaud E, Dahm P, Robertson C, Fitzsimons N, Albala D, Polascik TJ. Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. BJU Int. 2007 Jan 22. (2007) Abstract

Mouraviev V, Nosnik I, Sun L, Robertson CN, Walther P, Albala D, Moul JW, Polascik TJ. Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. Urology. 2007 Feb;69(2):311-4. (2007) Abstract

Mouraviev V, Nosnik I, Robertson C, Albala D, Walther P, Polascik TJ. Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience. Eur Urol. 2007 Mar;51(3):715-20; discussion 720-1. (2007) Abstract

Mouraviev V, Joniau S, Van Poppel H, Polascik TJ. Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol. 2007 Feb;51(2):328-36. (2007) Abstract

Moul JW, Sun L, Hotaling JM, Fitzsimons NJ, Polascik TJ, Robertson CN, Dahm P, Anscher MS, Mouraviev V, Pappas PA, Albala DM. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol. 2007 Feb;177(2):499-503; discussion 503-4. (2007) Abstract

Wiygul JB, Lallas C, Silverstein A, Polascik TJ. Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman. Urology. 2006 May;67(5):1085.e5-6. (2006) Abstract

Mouraviev V, Polascik TJ. Update on cryotherapy for prostate cancer in 2006. Curr Opin Urol. 2006 May;16(3):152-6. (2006) Abstract

Mouraviev V, Polascik TJ. Editorial comment. J Urol. 2006 Jun;175(6):2169. (2006) Abstract

Mouraviev V, Evans B, Polascik TJ. Salvage prostate cryoablation after primary interstitial brachytherapy failure: a feasible approach. Prostate Cancer Prostatic Dis. 2006;9(1):99-101. (2006) Abstract

Auge BK, Santa-Cruz RW, Polascik TJ. Effect of freeze time during renal cryoablation: a swine model. J Endourol. 2006 Dec;20(12):1101-5. (2006) Abstract

Wong TZ, Turkington TG, Polascik TJ, Coleman RE. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology. AJR Am J Roentgenol. 2005 Feb;184(2):676-80. (2005) Abstract

Wiygul JB, Evans BR, Peterson BL, Polascik TJ, Walther PJ, Robertson CN, Albala DM, Demark-Wahnefried W. Supplement use among men with prostate cancer. Urology. 2005 Jul;66(1):161-6. (2005) Abstract

Weizer AZ, Raj GV, O'Connell M, Robertson CN, Nelson RC, Polascik TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005 Dec;66(6):1176-80. (2005) Abstract

Raj GV, Brashears JH, Anand A, Paulson DF, Polascik TJ. Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Urology. 2005 Feb;65(2):332-6. (2005) Abstract

Polascik TJ, Given RW, Metzger C, Julian SR, Vestal JC, Karlin GS, Barkley CS, Bilhartz DL, McWhorter LT, Lacerna LV. Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases. Urology. 2005 Nov;66(5):1054-9. (2005) Abstract

Brashears JH 3rd, Raj GV, Crisci A, Young MD, Dylewski D, Nelson R, Madden JF, Polascik TJ. Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. J Urol. 2005 Jun;173(6):2160-5. (2005) Abstract

Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P. Promoter hypermethylation profile of kidney cancer. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3972-9. (2004) Abstract

Demark-Wahnefried W, Robertson CN, Walther PJ, Polascik TJ, Paulson DF, Vollmer RT. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology. 2004 May;63(5):900-4. (2004) Abstract

Santa-Cruz RW, Auge BK, Lallas CD, Preminger GM, Polascik TJ. Use of bipolar laparoscopic forceps to occlude and transect the retroperitoneal vasculature: a porcine model. J Endourol. 2003 Apr;17(3):181-5. (2003) Abstract

Raj GV, Reddan DJ, Hoey MF, Hoey MB, Polascik TJ. Management of small renal tumors with radiofrequency ablation. Urology. 2003 Jan;61(1):23-9. (2003) Abstract

Raj GV, Ellington KS, Polascik TJ. Autoimmune testicular vasculitis. Urology. 2003 May;61(5):1035. (2003) Abstract

Raj GV, Partin AW, Polascik TJ. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer. 2002 Feb 15;94(4):987-96. (2002) Abstract

Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002 Jul;168(1):273-80. (2002) Abstract

Polascik TJ, Bostwick DG, Cairns P. Molecular genetics and histopathologic features of adult distal nephron tumors. Urology. 2002 Dec;60(6):941-6. (2002) Abstract

Polascik TJ and Marshall FF:  Surgery for neoplastic involvement of the renal vein and inferior vena cava.  In:  Management of Urologic Malignancies.  Eds. Hamdy FC, Basler JW, Neal DE and Catalona WJ.  Churchill Livingstone, London, 2002

Polascik TJ and Marshall FF:  Partial nephrectomy.  In:  Management of Urologic Malignancies.  Eds. Hamdy FC, Basler JW, Neal DE and Catalona WJ.  Churchill Lovingstone, London, 2002. (2002)

Munver R, Threatt CB, Delvecchio FC, Preminger GM, Polascik TJ. Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study. Urology. 2002 Jul;60(1):170-5. (2002) Abstract

Rosenthal SA, Haseman MK, Polascik TJ. Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer. Tech Urol. 2001 Mar;7(1):27-37. (2001) Abstract

Reddan DN, Raj GV, Polascik TJ. Management of small renal tumors: an overview. Am J Med. 2001 May;110(7):558-62. (2001) Abstract

Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M, Vollmer RT. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001 Jul;58(1):47-52. (2001) Abstract

DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD, Robertson CN, Polascik TJ, Price DT. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2001 Jan 1;61(1):110-7. (2001) Abstract

Wolf, JS, Marcovich, R, Gill, IS, Sung, GT, Kavoussi, LR, Clayman, RV, McDougall, EM, Shalhav, A., Dunn, MD, Afane, JS, Moore, RG, Parra, RO, Winfield, HN, Sosa, RE, Chen, RN, Moran, ME, Nakada, SY, Hamilton, BD, Albala, DM, Koleski, F, Dass, S, Adams, JB, and Polascik, TJ. Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery. Urology 55: 831-836, 2000. (2000)

Wolf JS Jr, Marcovich R, Gill IS, Sung GT, Kavoussi LR, Clayman RV, McDougall EM, Shalhav A, Dunn MD, Afane JS, Moore RG, Parra RO, Winfield HN, Sosa RE, Chen RN, Moran ME, Nakada SY, Hamilton BD, Albala DM, Koleski F, Das S, Adams JB, Polascik TJ. Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery. Urology. 2000 Jun;55(6):831-6. (2000) Abstract

Raj, G. Subramanian, SV and Polascik, TJ. Advances in DVT prophylaxis in urology. Contemporary Urology 12(9): 56, 2000. (2000)

Munver, R, Donehower, RC, Kronz, JD, and Polascik, TJ. HIV infection presenting as an unusually large pure yolk sac tumor of the testis. J Urol. 164: 1653-1654, 2000. (2000)

Munver R, Donehower RC, Kronz JD, Polascik TJ. HIV infection presenting as an unusually large pure yolk sac tumor of the testis. J Urol. 2000 Nov;164(5):1653-4. (2000) Abstract

Haseman MK, Rosenthal SA, Polascik TJ. Capromab Pendetide imaging of prostate cancer. Cancer Biother Radiopharm. 2000 Apr;15(2):131-40. (2000) Abstract